Subsequent studies confirmed the association of PHOX2B mutations with NB predisposition [5]–[7], and showed that PHOX2B mutations could also be observed as de novo mutations in apparently sporadic tumors [8], [9]. This evidence concerns the gene PHOX2B and neuroblastoma.